(Q43824684)

27 November 2017

Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect (English)

1 reference

27 November 2017

1

1 reference

27 November 2017

3

1 reference

27 November 2017

Trop S

2

1 reference

27 November 2017

Jurim O

4

1 reference

27 November 2017

Diment J

5

1 reference

27 November 2017

Alper R

6

1 reference

27 November 2017

Rabbani E

7

1 reference

27 November 2017

Engelhardt D

8

1 reference

27 November 2017

Ilan Y

9

1 reference

27 November 2017

language of work or name

1 reference

1 November 2001

1 reference

27 November 2017

1 reference

27 November 2017

195

1 reference

27 November 2017

4

1 reference

27 November 2017

498-507

1 reference

Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease

27 November 2017

1 reference

Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation

21 January 2018

1 reference

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

21 January 2018

1 reference

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

21 January 2018

1 reference

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

21 January 2018

1 reference

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

21 January 2018

1 reference

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

21 January 2018

1 reference

Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice

21 January 2018

1 reference

Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors

21 January 2018

1 reference

Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses

21 January 2018

1 reference

Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period

21 January 2018

1 reference

Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat.

21 January 2018

1 reference

Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression

21 January 2018

1 reference

Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats

21 January 2018

1 reference

Immune responses to dietary antigens: oral tolerance.

21 January 2018

1 reference

NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function.

21 January 2018

1 reference

21 January 2018

1 reference

Antibodies to interleukin 12 abrogate established experimental colitis in mice

21 January 2018

1 reference

Inflammatory bowel disease (1)

21 January 2018

1 reference

Circulating immunoglobulin G1 antibody in patients with ulcerative colitis against the colonic epithelial protein detected by a novel monoclonal antibody

21 January 2018

1 reference

Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis

21 January 2018

1 reference

Bystander suppression induced by oral tolerance

21 January 2018

1 reference

Oral tolerization as a treatment of rheumatoid arthritis

21 January 2018

1 reference

Antigen-driven bystander suppression after oral administration of antigens

21 January 2018

1 reference

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

21 January 2018

1 reference

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells

21 January 2018

1 reference

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

21 January 2018

1 reference

Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.974

1 reference

27 November 2017

1 reference